<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Frutiger-UltraBlack,Bold" color="#4d67ad"/>
	<fontspec id="font1" size="9" family="Frutiger-UltraBlack,Bold" color="#007682"/>
	<fontspec id="font2" size="9" family="Courier" color="#007682"/>
	<fontspec id="font3" size="9" family="Frutiger-Light" color="#000000"/>
	<fontspec id="font4" size="9" family="Arial" color="#000000"/>
	<fontspec id="font5" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font6" size="24" family="Frutiger-UltraBlack,Bold" color="#000000"/>
	<fontspec id="font7" size="11" family="Helvetica-Black,Bold" color="#ffffff"/>
	<fontspec id="font8" size="14" family="GillSans-Light" color="#000000"/>
	<fontspec id="font9" size="16" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font10" size="15" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font11" size="11" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font12" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font13" size="6" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font14" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font15" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font16" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font17" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font18" size="8" family="GillSans" color="#000000"/>
	<fontspec id="font19" size="8" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font20" size="8" family="GillSans,Bold" color="#000000"/>
<text top="44" left="508" width="67" height="9" font="font0" id="p1_t1" reading_order_no="1" segment_no="1" tag_type="title">Bio Med Central<a href="http://www.biomedcentral.com/"><b>Bio</b></a></text>
<text top="756" left="503" width="51" height="10" font="font4" id="p1_t2" reading_order_no="58" segment_no="25" tag_type="text">Page 1 of 10<a href="http://www.biomedcentral.com/"><b>Med</b></a></text>
<text top="769" left="432" width="122" height="8" font="font5" id="p1_t3" reading_order_no="59" segment_no="26" tag_type="text">(page number not for citation purposes)<a href="http://www.biomedcentral.com/">Central</a></text>
<text top="35" left="55" width="241" height="23" font="font6" id="p1_t4" reading_order_no="0" segment_no="0" tag_type="title">BMC Biochemistry</text>
<text top="86" left="502" width="79" height="10" font="font7" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="title">Open Access<i>(page number not for citation purposes)</i></text>
<text top="87" left="55" width="86" height="13" font="font8" id="p1_t6" reading_order_no="3" segment_no="3" tag_type="title">Research article<b>BMC Biochemistry</b></text>
<text top="105" left="55" width="499" height="15" font="font9" id="p1_t7" reading_order_no="4" segment_no="4" tag_type="title">Targeted silencing of Jab1/Csn5 in human cells downregulates SCF<a href="http://www.biomedcentral.com/info/about/charter/"><b>Open Access</b></a></text>
<text top="123" left="55" width="366" height="15" font="font9" id="p1_t8" reading_order_no="5" segment_no="4" tag_type="title">activity through reduction of F-box protein levels</text>
<text top="140" left="55" width="306" height="14" font="font10" id="p1_t9" reading_order_no="6" segment_no="5" tag_type="text">Gregory A Cope 1,3 and Raymond J Deshaies* 1,2<b>Targeted silencing of Jab1/Csn5 in human cells downregulates SCF </b></text>
<text top="175" left="55" width="497" height="9" font="font12" id="p1_t10" reading_order_no="7" segment_no="6" tag_type="text">Address: 1 Department of Biology, California Institute of Technology Pasadena, CA 91125, USA, 2 Howard Hughes Medical Institute, 4000 Jones<b>activity through reduction of F-box protein levels</b></text>
<text top="185" left="55" width="440" height="8" font="font12" id="p1_t11" reading_order_no="8" segment_no="6" tag_type="text">Bridge Road, Chevy Chase, MD, 20815-6789, USA and 3 Department of Biology, Stanford University, Palo Alto, CA 94305, USA</text>
<text top="200" left="55" width="312" height="8" font="font12" id="p1_t12" reading_order_no="9" segment_no="7" tag_type="text">Email: Gregory A Cope - cope@caltech.edu; Raymond J Deshaies* - deshaies@caltech.edu</text>
<text top="211" left="55" width="92" height="8" font="font12" id="p1_t13" reading_order_no="10" segment_no="8" tag_type="text">* Corresponding author</text>
<text top="359" left="112" width="44" height="10" font="font14" id="p1_t14" reading_order_no="20" segment_no="16" tag_type="title">Abstract</text>
<text top="374" left="112" width="386" height="9" font="font15" id="p1_t15" reading_order_no="21" segment_no="17" tag_type="text">Background: SCF ubiquitin ligases target numerous proteins for ubiquitin dependent proteolysis,</text>
<text top="386" left="112" width="386" height="9" font="font16" id="p1_t16" reading_order_no="22" segment_no="17" tag_type="text">including p27 and cyclin E. SCF and other cullin-RING ligases (CRLs) are regulated by the ubiquitin-</text>
<text top="398" left="112" width="386" height="9" font="font16" id="p1_t17" reading_order_no="23" segment_no="17" tag_type="text">like protein Nedd8 that covalently modifies the cullin subunit. The removal of Nedd8 is catalyzed</text>
<text top="409" left="112" width="386" height="9" font="font16" id="p1_t18" reading_order_no="24" segment_no="17" tag_type="text">by the Jab1/MPN domain metalloenzyme (JAMM) motif within the Csn5 subunit of the Cop9</text>
<text top="421" left="112" width="51" height="9" font="font16" id="p1_t19" reading_order_no="25" segment_no="17" tag_type="text">Signalosome.</text>
<text top="438" left="112" width="385" height="9" font="font15" id="p1_t20" reading_order_no="26" segment_no="18" tag_type="text">Results: Here, we conditionally knock down Csn5 expression in HEK293 human cells using a</text>
<text top="450" left="112" width="386" height="9" font="font16" id="p1_t21" reading_order_no="27" segment_no="18" tag_type="text">doxycycline-inducible shRNA system. Cullin levels were not altered in CSN-deficient human cells,</text>
<text top="461" left="112" width="385" height="9" font="font16" id="p1_t22" reading_order_no="28" segment_no="18" tag_type="text">but the levels of multiple F-box proteins were decreased. Molecular analysis indicates that this</text>
<text top="473" left="112" width="386" height="9" font="font16" id="p1_t23" reading_order_no="29" segment_no="18" tag_type="text">decrease was due to increased Cul1- and proteasome-dependent turnover. Diminished F-box</text>
<text top="485" left="112" width="386" height="9" font="font16" id="p1_t24" reading_order_no="30" segment_no="18" tag_type="text">levels resulted in reduced SCF activity, as evidenced by accumulation of two substrates of the F-<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16401342">  </a></text>
<text top="497" left="112" width="242" height="9" font="font16" id="p1_t25" reading_order_no="31" segment_no="18" tag_type="text">box protein Fbw7, cyclin E and c-myc, in Csn5-depleted cells.<b>Abstract</b></text>
<text top="513" left="112" width="385" height="9" font="font15" id="p1_t26" reading_order_no="32" segment_no="19" tag_type="text">Conclusion: We propose that deneddylation of Cul1 is required to sustain optimal activity of SCF<b>Background: </b></text>
<text top="525" left="112" width="386" height="9" font="font16" id="p1_t27" reading_order_no="33" segment_no="19" tag_type="text">ubiquitin ligases by repressing 'autoubiquitination' of F-box proteins within SCF complexes, thereby</text>
<text top="537" left="112" width="173" height="9" font="font16" id="p1_t28" reading_order_no="34" segment_no="19" tag_type="text">rescuing them from premature degradation.</text>
<text top="586" left="55" width="60" height="10" font="font14" id="p1_t29" reading_order_no="35" segment_no="20" tag_type="title">Background</text>
<text top="598" left="55" width="241" height="9" font="font17" id="p1_t30" reading_order_no="36" segment_no="22" tag_type="text">Proteins are marked for degradation by the 26S proteas-</text>
<text top="610" left="55" width="241" height="9" font="font17" id="p1_t31" reading_order_no="37" segment_no="22" tag_type="text">ome via the covalent attachment of chains of the 76-</text>
<text top="621" left="55" width="241" height="9" font="font17" id="p1_t32" reading_order_no="38" segment_no="22" tag_type="text">amino acid protein ubiquitin [reviewed in [1]]. This proc-<b>Results: </b></text>
<text top="633" left="55" width="241" height="9" font="font17" id="p1_t33" reading_order_no="39" segment_no="22" tag_type="text">ess involves three discreet steps. First, ubiquitin is acti-</text>
<text top="645" left="55" width="241" height="9" font="font17" id="p1_t34" reading_order_no="40" segment_no="22" tag_type="text">vated by the ubiquitin conjugating enzyme (E1) through</text>
<text top="656" left="55" width="241" height="9" font="font17" id="p1_t35" reading_order_no="41" segment_no="22" tag_type="text">the hydrolysis of ATP to AMP to yield a high energy</text>
<text top="668" left="55" width="241" height="9" font="font17" id="p1_t36" reading_order_no="42" segment_no="22" tag_type="text">thioester intermediate between the C-terminal glycine of</text>
<text top="680" left="55" width="190" height="9" font="font17" id="p1_t37" reading_order_no="43" segment_no="22" tag_type="text">ubiquitin and the catalytic cysteine of the E1.</text>
<text top="704" left="55" width="241" height="9" font="font17" id="p1_t38" reading_order_no="44" segment_no="24" tag_type="text">Subsequently, ubiquitin is transferred onto the catalytic</text>
<text top="715" left="55" width="241" height="9" font="font17" id="p1_t39" reading_order_no="45" segment_no="24" tag_type="text">cysteine of one of many ubiquitin conjugating enzymes<b>Conclusion: </b></text>
<text top="586" left="313" width="241" height="9" font="font17" id="p1_t40" reading_order_no="46" segment_no="21" tag_type="text">(E2) which, in turn, transfer their cargo onto substrates</text>
<text top="598" left="313" width="198" height="9" font="font17" id="p1_t41" reading_order_no="47" segment_no="21" tag_type="text">with the help of ubiquitin ligase enzymes (E3).</text>
<text top="621" left="313" width="241" height="9" font="font17" id="p1_t42" reading_order_no="48" segment_no="23" tag_type="text">One of the best-studied E3 ubiquitin ligase enzymes is the</text>
<text top="633" left="313" width="241" height="9" font="font17" id="p1_t43" reading_order_no="49" segment_no="23" tag_type="text">four subunit complex SCF [reviewed in [2]]. SCF consists<b>Background</b></text>
<text top="645" left="313" width="241" height="9" font="font17" id="p1_t44" reading_order_no="50" segment_no="23" tag_type="text">of two activities: the first, contained within the Cul1 and</text>
<text top="656" left="313" width="241" height="9" font="font17" id="p1_t45" reading_order_no="51" segment_no="23" tag_type="text">RING domain Hrt1/Roc1/Rbx1 proteins, is the ability to</text>
<text top="668" left="313" width="241" height="9" font="font17" id="p1_t46" reading_order_no="52" segment_no="23" tag_type="text">recruit and activate the E2 to facilitate ubiquitin transfer<a href="">ed in [1]]. This</a> proc-</text>
<text top="680" left="313" width="241" height="9" font="font17" id="p1_t47" reading_order_no="53" segment_no="23" tag_type="text">from the E2 onto substrate; the second resides within the</text>
<text top="692" left="313" width="241" height="9" font="font17" id="p1_t48" reading_order_no="54" segment_no="23" tag_type="text">variable F-box proteins, which are linked to Cul1 via Skp1</text>
<text top="704" left="313" width="241" height="9" font="font17" id="p1_t49" reading_order_no="55" segment_no="23" tag_type="text">and are thought to recruit substrates for ubiquitination by</text>
<text top="715" left="313" width="241" height="9" font="font17" id="p1_t50" reading_order_no="56" segment_no="23" tag_type="text">the Cul1/Hrt1 sub-complex. The large number of different</text>
<text top="727" left="313" width="241" height="9" font="font17" id="p1_t51" reading_order_no="57" segment_no="23" tag_type="text">F-box proteins gives SCF the opportunity to access a wide</text>
<text top="254" left="55" width="86" height="7" font="font18" id="p1_t52" reading_order_no="11" segment_no="9" tag_type="text">Published: 09 January 2006</text>
<text top="268" left="55" width="87" height="7" font="font19" id="p1_t53" reading_order_no="12" segment_no="12" tag_type="text">BMC Biochemistry 2006, 7 :1</text>
<text top="268" left="151" width="88" height="7" font="font18" id="p1_t54" reading_order_no="13" segment_no="12" tag_type="text">doi:10.1186/1471-2091-7-1</text>
<text top="254" left="310" width="97" height="7" font="font18" id="p1_t55" reading_order_no="18" segment_no="10" tag_type="text">Received: 23 September 2005</text>
<text top="263" left="310" width="87" height="7" font="font18" id="p1_t56" reading_order_no="19" segment_no="11" tag_type="text">Accepted: 09 January 2006</text>
<text top="282" left="55" width="244" height="7" font="font18" id="p1_t57" reading_order_no="14" segment_no="13" tag_type="text">This article is available from: http://www.biomedcentral.com/1471-2091/7/1<a href="">wed in [2]]. SCF consist</a>s</text>
<text top="297" left="55" width="189" height="7" font="font18" id="p1_t58" reading_order_no="15" segment_no="14" tag_type="text">© 2006 Cope and Deshaies; licensee BioMed Central Ltd.</text>
<text top="306" left="55" width="492" height="7" font="font18" id="p1_t59" reading_order_no="16" segment_no="15" tag_type="text">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),</text>
<text top="315" left="55" width="400" height="7" font="font18" id="p1_t60" reading_order_no="17" segment_no="15" tag_type="text">which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</text>
</page>
</pdf2xml>
